Skip to content

HeartFlow

Heartflow provides non-invasive, personalized cardiac testing to improve the diagnosis and management of coronary artery disease.

40

Overview

Heartflow offers a non-invasive approach to diagnosing and managing coronary artery disease (CAD), a condition that remains a leading cause of death worldwide. The company's platform, known as the Heartflow Analysis, combines anatomical and functional data from a standard coronary CT angiogram to help clinicians assess the severity of CAD without the need for invasive procedures. This technology is designed for cardiologists, radiologists, and healthcare systems looking to improve patient outcomes and reduce unnecessary testing.

The Clinical Challenge

Conventional diagnostic methods for CAD often provide incomplete or misleading information, which can lead to undiagnosed disease, unnecessary procedures, incorrect treatment plans, and increased costs. Heartflow aims to address these gaps by offering a more comprehensive, personalized assessment that supports better clinical decision-making.

How Heartflow Analysis Works

The Heartflow Analysis includes several components: FFR CT Analysis, Roadmap Analysis, and Plaque Analysis. FFR CT Analysis calculates fractional flow reserve from CT images, providing insight into the functional significance of coronary blockages. Roadmap Analysis creates a personalized 3D model of the coronary arteries to aid in procedural planning. Plaque Analysis quantifies and characterizes plaque burden, which can inform risk assessment and treatment strategies. Together, these tools offer a multifaceted view of a patient's coronary health.

PCI Navigator Tool

The PCI Navigator tool is part of the Heartflow offering, designed to assist interventional cardiologists in planning percutaneous coronary intervention (PCI) procedures. By integrating data from the Heartflow Analysis, it helps clinicians determine the optimal approach for stent placement and other interventions, potentially improving procedural outcomes.

Availability and Regulatory Status

The Heartflow Analysis is commercially available in the United States, with specific functionalities also available in the European Union, United Kingdom, Japan, Canada, and other select regions. The company holds ISO 13485 certification for quality management of medical devices and SOC certification, indicating adherence to rigorous standards for data security and quality.

Intended Use and Limitations

Heartflow Analysis is intended to be used in conjunction with a patient's clinical history, symptoms, and other diagnostic data, as well as the clinician's professional judgment. It may not be appropriate for all patients, and clinicians should consult the Indications for Use and safety information for additional details. The information provided by Heartflow Analysis is not a substitute for clinical expertise but rather a tool to enhance it.

The Vision Behind Heartflow

Heartflow's stated vision is to transform CAD from the leading cause of death into a disease that can be managed for life. By providing non-invasive, actionable insights, the company seeks to shift the paradigm of CAD management toward earlier detection, more precise treatment, and improved long-term patient care. This vision aligns with broader trends in healthcare toward personalized, data-driven approaches that prioritize patient safety and outcomes.

Core features

  • Heartflow Analysis, including FFR CT Analysis, Roadmap Analysis, and Plaque Analysis
  • PCI Navigator tool for procedural planning
  • Commercially available in the United States, with specific functionalities in the EU, UK, Japan, Canada, and other regions
  • Intended for use in conjunction with clinical history, symptoms, and other diagnostic data
  • ISO 13485 and SOC certified

Use cases

  1. 1Assessing coronary artery disease non-invasively
  2. 2Planning percutaneous coronary intervention (PCI) procedures
  3. 3Evaluating plaque burden and composition
  4. 4Guiding treatment decisions for patients with suspected CAD

Strengths and things to check

Strengths

  • Provides functional and anatomical information from a single non-invasive test
  • May reduce unnecessary invasive procedures
  • Commercially available in multiple regions
  • Backed by quality management certifications

Things to check

  • Not appropriate for all patients; indications for use should be consulted
  • Results must be interpreted alongside clinical history and other diagnostic data
  • Availability of specific functionalities varies by region

Pricing

Subscription pricing is not listed.

Basic information

Added
Oct 10, 2026
Platforms
Web
Chinese & English
Not marked
API
Marked as supported
Self-hosting
Not marked
Best for
Cardiologists, radiologists, and healthcare systems seeking advanced, non-invasive diagnostic tools for coronary artery disease.
Information updated
Oct 16, 2026
Website status
Checking
Corrections · Privacy · Data requests?
Contact us

Features, pricing and availability may change. Always verify details on the official website. Maintained by steven · Last updated Oct 16, 2026 →

Related tools

All categories

NeuroFlow

Enterprise Grade

NeuroFlow is a behavioral health analytics and engagement platform for payers, health systems, and federal agencies that need to surface hidden risk, route members to care, and measure outcomes at population scale.

Enterprise GradeAPI Available
60
PaidSOC 2
View details

Nabla

Enterprise Grade

Nabla is a clinical AI layer that captures patient-clinician conversations and generates structured notes, dictation, and coding suggestions inside Epic and major EHRs.

Enterprise GradeAPI Available
60
Free TierSOC 2
View details